Evaluación del impacto de la utilización de medicamentos en dosis unitarias en 2 centros de atención primaria

OBJECTIVE: To evaluate the economical impact of using medications packaged in a single dose non-reusable container (Onedose(®)), compared to prescribing preparations in the usual multidose containers. DESIGN: We performed a cost-minimization analysis from a prescribing center's perspective. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Segú Tolsà, Jose Luis, Rubio Dalmau, Ana, Pérez López, Sonia, Fernández Roure, Jose Luis, Serrat Torres, Josep, Modamio Charles, Pilar, Mariño Hernández, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985482/
https://www.ncbi.nlm.nih.gov/pubmed/23643645
http://dx.doi.org/10.1016/j.aprim.2013.02.003
_version_ 1783491810675392512
author Segú Tolsà, Jose Luis
Rubio Dalmau, Ana
Pérez López, Sonia
Fernández Roure, Jose Luis
Serrat Torres, Josep
Modamio Charles, Pilar
Mariño Hernández, Eduardo
author_facet Segú Tolsà, Jose Luis
Rubio Dalmau, Ana
Pérez López, Sonia
Fernández Roure, Jose Luis
Serrat Torres, Josep
Modamio Charles, Pilar
Mariño Hernández, Eduardo
author_sort Segú Tolsà, Jose Luis
collection PubMed
description OBJECTIVE: To evaluate the economical impact of using medications packaged in a single dose non-reusable container (Onedose(®)), compared to prescribing preparations in the usual multidose containers. DESIGN: We performed a cost-minimization analysis from a prescribing center's perspective. The observational study design is retrospective and analyzes 23 products in prescriptions made between January and April 2012. SETTING: Two Spanish Primary Care Centers located in the province of Barcelona. The first covered an urban area with a population of 24.500 people, and the second a semi-urban area with 10.000 people. PRIMARY OUTCOME MEASURES: Each examined product was measured between January and April 2012 and extrapolated annually, based on the defined substitution scenarios results of total Euro savings in non-prescribed doses and price differences. RESULTS: The Savings related to the substitution of the prescribed packaging presentations with Onedose(®) were 45.000 Euros (24%) in the months of analysis and 133.000 Euros annually, avoiding the use of 212.000 doses (14%) in the period analyzed and 669.000 doses annually. CONCLUSIONS: The use of single dose non-reusable container packaging (Onedose(®)) in the analyzed health centers reduced prescription-related expenses without increasing dispensing costs, thus reducing the household stock of those medicines which are not objectively suitable to be used without a previous diagnosis.
format Online
Article
Text
id pubmed-6985482
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69854822020-01-30 Evaluación del impacto de la utilización de medicamentos en dosis unitarias en 2 centros de atención primaria Segú Tolsà, Jose Luis Rubio Dalmau, Ana Pérez López, Sonia Fernández Roure, Jose Luis Serrat Torres, Josep Modamio Charles, Pilar Mariño Hernández, Eduardo Aten Primaria Originales OBJECTIVE: To evaluate the economical impact of using medications packaged in a single dose non-reusable container (Onedose(®)), compared to prescribing preparations in the usual multidose containers. DESIGN: We performed a cost-minimization analysis from a prescribing center's perspective. The observational study design is retrospective and analyzes 23 products in prescriptions made between January and April 2012. SETTING: Two Spanish Primary Care Centers located in the province of Barcelona. The first covered an urban area with a population of 24.500 people, and the second a semi-urban area with 10.000 people. PRIMARY OUTCOME MEASURES: Each examined product was measured between January and April 2012 and extrapolated annually, based on the defined substitution scenarios results of total Euro savings in non-prescribed doses and price differences. RESULTS: The Savings related to the substitution of the prescribed packaging presentations with Onedose(®) were 45.000 Euros (24%) in the months of analysis and 133.000 Euros annually, avoiding the use of 212.000 doses (14%) in the period analyzed and 669.000 doses annually. CONCLUSIONS: The use of single dose non-reusable container packaging (Onedose(®)) in the analyzed health centers reduced prescription-related expenses without increasing dispensing costs, thus reducing the household stock of those medicines which are not objectively suitable to be used without a previous diagnosis. Elsevier 2013-11 2013-05-03 /pmc/articles/PMC6985482/ /pubmed/23643645 http://dx.doi.org/10.1016/j.aprim.2013.02.003 Text en © 2012 Elsevier España, S.L. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Originales
Segú Tolsà, Jose Luis
Rubio Dalmau, Ana
Pérez López, Sonia
Fernández Roure, Jose Luis
Serrat Torres, Josep
Modamio Charles, Pilar
Mariño Hernández, Eduardo
Evaluación del impacto de la utilización de medicamentos en dosis unitarias en 2 centros de atención primaria
title Evaluación del impacto de la utilización de medicamentos en dosis unitarias en 2 centros de atención primaria
title_full Evaluación del impacto de la utilización de medicamentos en dosis unitarias en 2 centros de atención primaria
title_fullStr Evaluación del impacto de la utilización de medicamentos en dosis unitarias en 2 centros de atención primaria
title_full_unstemmed Evaluación del impacto de la utilización de medicamentos en dosis unitarias en 2 centros de atención primaria
title_short Evaluación del impacto de la utilización de medicamentos en dosis unitarias en 2 centros de atención primaria
title_sort evaluación del impacto de la utilización de medicamentos en dosis unitarias en 2 centros de atención primaria
topic Originales
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985482/
https://www.ncbi.nlm.nih.gov/pubmed/23643645
http://dx.doi.org/10.1016/j.aprim.2013.02.003
work_keys_str_mv AT segutolsajoseluis evaluaciondelimpactodelautilizaciondemedicamentosendosisunitariasen2centrosdeatencionprimaria
AT rubiodalmauana evaluaciondelimpactodelautilizaciondemedicamentosendosisunitariasen2centrosdeatencionprimaria
AT perezlopezsonia evaluaciondelimpactodelautilizaciondemedicamentosendosisunitariasen2centrosdeatencionprimaria
AT fernandezrourejoseluis evaluaciondelimpactodelautilizaciondemedicamentosendosisunitariasen2centrosdeatencionprimaria
AT serrattorresjosep evaluaciondelimpactodelautilizaciondemedicamentosendosisunitariasen2centrosdeatencionprimaria
AT modamiocharlespilar evaluaciondelimpactodelautilizaciondemedicamentosendosisunitariasen2centrosdeatencionprimaria
AT marinohernandezeduardo evaluaciondelimpactodelautilizaciondemedicamentosendosisunitariasen2centrosdeatencionprimaria